About ProcartaPlex strengths for Luminex platform
About ProcartaPlex strengths for Luminex platform
- It is not combinable with simplexes or other panels.
- ProcartaPlex preconfigured panels are widely tested for combinationability, interference and cross-reactivity of analytes to provide the highest level of validation and accuracy
- Panels are available in several formats for six species (human, mouse, rat, non-human primate, pig and dog)
- Provide with the reagents necessary to perform the dosing
- Target list [microbead region]: beta-2-microglobulin (B2M) [21], cathepsin D [44], CEA (CEACAM-5) [52], EGFR (ErbB1) [37], haptoglobin [63], HGFR (c-Met) [25], IGFBP-2 [76], IGFBP-3 [13], MIA [75], MIP-4 (CCL18) [61], periostin (OSF-2) [62], VE-cadherin [28]
- The recommended pre-dillution for serum and plasma samples is 1:100
- ProcartaPlex immunoassays are based on the principles of a sandwich ELISA
- They use two highly specific antibodies binding to different epitopes of a protein to simultaneously quantify all protein targets using a Luminex instrument
- ProcartaPlex multiplex assays require up to 25 μl of plasma or serum, or 50 μl of cell culture supernatant
- The results analysed can be obtained in just four hours
- Validated as the most demanding panel on the market, including the combination of protein targets and cross-reactivity tests
- Luminex technology is the most referenced multixing platform for protein detection and quantitative analysis
Panel 2 targets 12 protein-related...
Panel 2 targets 12 proliferation and metastasis proteins using Luminex xMAP technology
This panel contains protein markers...
This panel contains important marker proteins associated with cancer progression, such as those involved in cell proliferation, tumour cell migration, tissue invasion and cancer.
Analysis of these biomarkers could help...
Analysis of these biomarkers could help to highlight physiological conditions prior to tumour progression
Provided in a ready-to-use format with...
Provided in a ready-to-use format with individual vials of capture and detection reagents formulated at a concentration of 1X.
This format requires less pipeting and less...
This format requires less pipeting and experimental configuration
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17490743 |
| Specifications |
| Product type | Multiplex panel |
| Quantity | 96 dosages |
| Species | Human |
| Combinability | Not combinable |
| Sensitivity of the dosage | See Certificate of Analysis |
| Dose range | See Certificate of Analysis |
| Format | Multiplex kit |
| For use with (equipment) | Luminex™ Instruments |
| Coefficient of inter-dose variation | Less than 15 % |
| Coefficient of intra-dose variation | Less than 15 % |
| Product range | ProcartaPlex™ |
| Type of sample | Serum, plasma, cell culture supernatants, Plasma, Cell Culture Supernatants |
| dimResearchArea | Oncology |
| Physical characteristics |
| Multiplex, size Plex n° | 12 |
| Volume of sample | Serum, plasma: 25 µl, cell culture supernatant: 50 µl |
| Storage and shipping |
| Content and storage | • 2 human standard 8 (lyophilized) blend vials • 1 vial of capture microbeads (1X) • 1 bottle of biotinylated antibody mixture (1X) • 1 vial of reading pad (1X) • 1 vial of Streptavidine-PE (1X) • 1 vial of universal dosing buffer (10 |
Origin and customs
| Manufacturer ref. | EPX120-15842-901 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.